Application of herbal medicine composition in the preparation of medicine for treating neurological disorders
A Chinese herbal medicine composition effectively treats facial nerve disorders by enhancing nerve function and promoting regeneration through improved blood circulation and protein expression, addressing the limitations of current treatments.
Patent Information
- Application Number
- JP2024510249
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-12-03
- Filing Date
- 2022-12-01
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2042-12-01
AI Technical Summary
Current treatments for neurological disorders, particularly facial nerve disorders, are lengthy, require frequent prescription adjustments, and may lead to recurrence of symptoms due to increased patient consultations, and some herbal remedies have side effects or prolonged treatment periods.
A Chinese herbal medicine composition comprising Jingkuta, Windproof, Qianghu, Dokatsu, Saiku, KawaKyuu, Bellflower, and Licorice is developed, formulated into granules or dispersions, to improve blood circulation, expel colds, and enhance nerve function recovery.
The herbal composition significantly alleviates facial paralysis symptoms, enhances nerve transmission, promotes axon regeneration, and improves facial nerve function by increasing VEGFb, VEGFR1, and VEGFR2 protein expression, while suppressing Beclin1 and increasing P62 protein levels.
Smart Images

Figure 0007588759000009 
Figure 0007588759000010 
Figure 0007588759000011
Abstract
Description
[Technical field]
[0001] The present invention belongs to the field of traditional Chinese medicine technology, and relates to a traditional Chinese medicine composition and its application, particularly to a traditional Chinese medicine composition and its application in treating neurological disorders. [Background technology]
[0002] Neuropathy specifically refers to peripheral nerve disease, a group of organic disorders that occur in the peripheral nervous system. According to the location and function of the nerves, the nervous system can be divided into the central nervous system and the peripheral nervous system. Facial nerve disorder, also known as facial nerve paralysis, is paralysis of the facial muscles, and is mainly manifested as motor disorders of the facial muscles. The clinical symptoms of facial nerve paralysis are mainly bilateral facial muscle paralysis with one eyelid and one eyelid.
[0003] In traditional Chinese medicine, this condition is called "mouth distorted and eyes slanted," and among the general public, it is also known as "hanging line wind" or "▲Miao▼quan wind." This occurs when the body lacks positive energy, the channels are empty, and cold takes advantage of this gap to enter the Yangming vein in the middle head, causing one side of the face to become disharmony with the Yingwei (a symptom of sweating due to cold), and the qi and blood are blocked, preventing nutrients from reaching the meridians, resulting in symptoms. Among these, there are two types: wind-cold exterior symptoms and wind-heat exterior symptoms.
[0004] Wind-cold external symptoms often develop suddenly, with the corners of the mouth leaning to one side, inability to close the eyelids, chills, headaches, stuffy nose, tight facial skin, muscle and joint pain, and other symptoms. The tongue is pale red with a thin, white coating, and the pulse is raised and taut. Treatment involves the use of the wind-dispersing cold method, which expels phlegm and improves pulse flow. The main prescription is Sanbai Gochuto: 20g of White Peony Root, 15g of White Aconite Root, 6g of White Aconite Root, 15g of Silkworm Root, 15g of Cicada-Removing Cicada, 15g of Stir-Fried Earth Dragon, 10g of Scorpion, 2 Centipede (separate), 10g of Fangfeng, 10g of Chuanqiu, 20g of Chotoukou, and 30g of Astragalus. The above herbs are boiled twice in water, except for Centipede, and taken once a day, twice a day, morning and evening. Centipede is heated on a tile until scorched, then crushed into powder and dissolved in a decoction twice a day for consumption. The prescription contains Bo Feng, Baishi, Bai Fu Zi, and Diao Teng Kang, which have the effect of expelling the evils of cold and chill, regulating blocked channels, and improving the circulation of blood qi. The "five insects (Silkworm, Cicada Tai, Earth Dragon, Scorpion, and Centipede)" move quickly, and are effective in expelling cold and improving the qi of the channels. White Peony and Chuan Qi improve the circulation of blood qi and expel cold. Astragalus replenishes qi, boosts immunity, and expels cold. The combination of various herbal medicines expels evil and boosts immunity. It also removes wind-cold external symptoms, nourishes channels, and improves blood flow, which can cure facial paralysis.
[0005] Wind-heat syndrome develops suddenly without any symptoms, and symptoms include facial distortion, hot face, headache or fever, mental confusion, bitter taste in the mouth, dry and sore throat, hard bowel movements, yellow urine, etc. The tip of the tongue is red, the tongue coating is pale yellow, and the pulse is rapid and floating. Treatment is to disperse the cold, lower the fever, activate the blood, and improve the flow of qi in the blocked channels. The main prescription uses Jia Wei Qian Zheng San: Quan Zhao 7g, Bai Aconite 7g, Xia Silkworm 7g, 2 Centipede, 7g Dilong, 10g of Angelica, 10g of White Peony, 10g of Szechuan Xiangyang, 10g of Fangfeng, 10g of Diao Teng Kang, 15g of Forsythia Fruit, 15g of Banlan Root, and 15g of Big Green Leaf. The Bai Aconite in the prescription is spicy and warm, has the effect of invigorating and dissipating, clearing cold, eliminating phlegm, and improving the flow of qi in the channels, and is the main medicine (the main therapeutic agent in the prescription). Quan Zhao, Bai Xia Silkworm, and Dilong have the effect of dispersing cold and stopping convulsions, among which Bai Xia Silkworm also has the effect of eliminating phlegm, and Quan Zhao has the effect of improving the flow of qi in the channels. Centipede and Diao Teng Kang also have the effect of dispersing cold and improving the flow of qi in the meridians. Angelica, White Peony, Szechuan Mushroom, and Feng Feng have the effect of dispersing cold and improving the flow of qi in the meridians, and invigorate the blood. They were selected because "to cure a cold, you must first invigorate the blood, and once blood circulation is improved, the cold will naturally be cured." Forsythia Fruit, Banlan Root, and Biging Leaf have the effects of clearing heat, transforming dampness, and detoxifying. These herbs improve the flow of qi in the facial meridians, act on the affected area, and eliminate cold.
[0006] CN108201592A has announced an oral herbal medicine for facial paralysis caused by nerve disorders, the raw materials and weight parts are: Bupleurum Root 30g, Scutellaria Root 17g, Scutellaria Root 14g, Fangfeng Root 15g, Bai Aconite Root 15g, Tianma Root 15g, Quan Scorpion Root 15g, Licorice Root 10g, Scutellaria Root 15g, Qian Huo Root 20g, and Dilong 20g. Tianma has a very good effect on improving the Qi of the channels, but it has strong side effects. Scutellaria Root is also very irritating, easily irritating the stomach and intestines, and has the side effect of damaging the gastric mucosa. The treatment period with the herbal medicine provided by this patent is long, and the disease can be cured after about 11 courses of treatment.
[0007] There have been reports that nerve disorders are currently being treated with a prescription based on Jingfang Baidu San, which varies the ratio of ingredients used.
[0008] In the 5th edition of the Chinese Traditional Medicine Journal, it was reported that facial paralysis caused by wind-cold attack on the outer middle meridian (cerebrovascular disorder) was treated by adjusting the ratio of ingredients based on the prescription of Jingfang Baidu San. First diagnosis: Jingjiang 10g, Fangfeng 10g, Bupleurum Root 12g, Scutellaria Root 10g, Qiang Huo 10g, Angelica Root 10g, Szechuan Mucuna 12g, Mint 10g, Gold and Silver Flower 10g, Forsythia Fruit 10g, White Flower Snake Tongue 10g, Pueraria Root 20g, White Flower Snake Tongue Grass 15g, Red Peony Root 10g, Burdock Fruit 10g, Licorice Root 9g. Two preparations. Take one preparation a day, divided into three doses. 2nd diagnosis: Based on the 1st prescription, Angelica and White ▲ Shi▼ were removed, and 10g of Angelica Root, 6g of Semitaia, 10g of Shengma, 10g of Gobo Fruit, and 10g of Acorus Calamus were added, and 2 medicines were prescribed. 3rd diagnosis: 10g of Red Peony Root, 6g of Chuan▲ Kyu▼, 10g of Angelica Root, 10g of Earth Dragon, 20g of Astragalus Root, 20g of Pueraria Root, 10g of Shengma, 9g of Semitaia, 6g of Quan Scorpion, 20g of Irei Sen, 15g of White Hebi Shisou, 10g of Xingxian, 1 of Centipede, and 6g of Licorice. 2 medicines, 1 medicine per day, 3 times a day. 4th diagnosis: The above prescription was slightly modified, and 2 medicines were prescribed for prognosis. After two doses, the face swelling test showed no air leakage from the left corner of the mouth, there was no discomfort in the face, and the symptoms had disappeared. A total of eight medications were taken. The published content used a prescription that increased or decreased Jingbang Baidu San, diagnosed the symptoms, and divided the treatment into stages. Although the treatment period was short, changing the prescription every two medications increased the number of consultations with the patient, which may increase the probability of the patient suffering from wind-cold external symptoms again.
[0009] In addition, the Jingfang Haidokusan formulation is a modern herbal formulation developed from the formula of Jingfang Haidokusan, and is made from Qiang Huo, Angelica Root, Poria Cocos, Fangfeng, Jingjie, Szechuan Moxibustion, Platycodon Root, Bupleurum Root, Qianhu, Citrus Fruit Root, and Licorice Root. Fangfeng, Jingjie, and Qiang Huo are spicy and warm, and cause sweating, which has the effect of expelling evil and dissipating cold. Bupleurum Fruit Root further strengthens the effect of promoting sweating, Angelica Root expels cold and removes stagnant dampness in the body, Szechuan Moxibustion expels cold and activates blood qi, and Citrus Fruit Root improves the flow of qi and relieves chest congestion. The sweating caused by various herbs expels cold, improves blood circulation and the flow of qi in the veins, eliminates phlegm and toxins, lowers fever, and removes stagnant dampness. At present, there is no information published regarding the use of Jingfang Baidu Powder in the treatment of facial nerve disorders.
[0010] Invention Contents The present invention is based on the commercially available products "Jingfang Saidoku San Granules" and "Jingfang Saidoku San Preparations" and has been developed further with regard to their uses. The trigger for the development was feedback from an employee. After the employee developed facial paralysis due to prolonged exposure to air conditioning, he took Jingfang Saidoku San Granules daily to prevent colds during the period when he was receiving standard treatment for facial paralysis, and noticed that the symptoms of facial paralysis were significantly improved and the treatment period for facial nerve disorder was significantly shortened. Inspired by the employee's feedback, the inventor began to further research the use of Jingfang Saidoku San Preparations in the treatment of nerve disorders, especially facial nerve disorders.
[0011] The first object of the present invention is to provide a Chinese herbal medicine composition for treating neuropathy, which comprises: Root of Qiang Huo, Angelica Root, Poria Cocos, Fangfeng, Scutellaria Baicalensis, Szechuan Lovage Rhizome, Platycodon Root, Bupleurum Root, Chinese Herb, Citrus Fruit, and Licorice Root.
[0012] In addition, the herbal composition includes the following herbal ingredients: Jingku 50-100 parts by weight Windproof 50-100 parts by weight Qianghu 50-100 parts by weight Dokatsu 50-100 parts by weight Saiba 50-100 parts by weight Qianhu 50-100 parts by weight 50-100 parts by weight of cucumber, 50-100 parts by weight of kiwi fruit, 50-100 parts by weight of poria. Bellflower 50-100 parts by weight Licorice 5-50 parts by weight.
[0013] Preferably, the herbal composition comprises the following herbal ingredients: Jingkuta 75 parts by weight Windproof 75 parts by weight Qianghu 75 parts by weight Dokukatsu 75 parts by weight Saiku 75 parts by weight Qianhu 75 parts by weight 75 parts by weight of cucumber, 75 parts by weight of kiwi fruit, 75 parts by weight of poria. Bellflower 75 parts by weight Licorice 25 parts by weight.
[0014] The nerve disorders include facial nerve disorder, trigeminal neuralgia, and polyneuropathy.
[0015] The above-mentioned nerve disorders are caused by one or more of the following causes: infection, toxic substances, genetic factors, nutritional disorders, immune diseases, metabolic disorders, endocrine metabolic disorders, congenital malformations, blood circulation disorders, hyperplasia, exposure to cold, and injuries.
[0016] Furthermore, the herbal composition can improve the symptoms of neuropathy, which include irritation symptoms and / or deficit symptoms. Irritation symptoms are manifested as pain and numbness, and deficit symptoms are manifested as hypoesthesia / loss and motor paralysis.
[0017] Specifically, the nerve disorder is preferably facial nerve disorder. The herbal composition can improve the symptoms of facial nerve disorder, including shallow nasolabial folds, one-sided corners of the mouth, water dripping from the mouth, inability to move the face voluntarily, widening of the palpebral fissures, wrinkles, inability to close the eyes, inability to whistle, inability to make facial expressions, etc.
[0018] Furthermore, the herbal composition may be formulated together with pharma- ceutically acceptable additives.
[0019] The preparations include granules, combinations, tablets, capsules, powders, syrups, microcapsules, and ointments, and are preferably Jingbo-Raito-Doku Powder Granules and Jingbo-Raito-Doku Powder Combinations.
[0020] The second object of the present invention is to provide an application of the Jingbo Baidu Powder preparation as a therapeutic agent for nerve disorders.
[0021] The third object of the present invention is to provide an application of the Jingbo Baidu Powder preparation for treating facial nerve disorders.
[0022] The Jingbo-haidoku powder preparations described in the present invention include, but are not limited to, Jingbo-haidoku powder granules and Jingbo-haidoku powder mixtures. The preparations of the Chinese herbal composition prepared from the above raw herbs are all included in the Jingbo-haidoku powder preparations.
[0023] Compared with existing technologies, the present invention has significant advantages: (1) The herbal composition of the present invention can clearly improve symptoms associated with facial nerve paralysis, movement disorder, etc., caused by facial nerve disorder in rats.
[0024] (2) The herbal composition of the present invention can significantly enhance the expression of VEGFB, VEGFR1 and VEGFR2 proteins in the lateral nerve of rats after surgery, and promote the recovery and regeneration of injured axons.
[0025] (3) The herbal composition of the present invention can stimulate facial nerve transmission in rats and increase the nerve conduction velocity.
[0026] (4) The herbal medicine composition of the present invention can suppress the expression of Beclin 1 protein in the facial nerve of rats, enhance the expression of P62, and participate in the autophagy control mechanism, thereby promoting the functional recovery of the facial nerve. [Brief description of the drawings]
[0027] [Figure 1] Figure 1-2: Comparison of facial nerve conduction velocity on one side after surgery in each group of rats after 14 days of drug administration. [Diagram 2]Figure 1-2: Comparison of facial nerve conduction velocity on one side after surgery in each group of rats after 14 days of drug administration. [Diagram 3] Figure 3-4: Comparison of Beclin 1 protein levels in the facial nerve tissue of rats in each group after 14 days of drug administration. [Figure 4] Figure 3-4: Comparison of Beclin 1 protein levels in the facial nerve tissue of rats in each group after 14 days of drug administration. [Diagram 5] Figure 5-6: Comparison of the amount of P62 protein found in the facial nerve tissue of each group of rats after 14 days of drug administration. [Figure 6] Figure 5-6: Comparison of the amount of P62 protein found in the facial nerve tissue of each group of rats after 14 days of drug administration.
[0028] Detailed experimental method In order to make the objectives and technical solutions of the present invention clearer and easier to understand, the contents of the present invention will be described in more detail by examples, but in this respect, it should not be understood that the present invention is limited to the following examples within the scope of the subject matter of the present invention described above. In addition, the corresponding replacement or modification made according to ordinary technical knowledge and conventional means in the art without departing from the above technical premise of the present invention is included in the present invention. Example 1 Granule preparation (commercially available Jingbo Haidokusan granules) Formulation: Jinghu 75g Windproof 75g Qianghu 75g Dokatsu 75g Saihu 75g Qianhu 75g Kawa▲Kyu▼ 75g, Kikko 75g, Poria cocos 75g, Platycodon grandiflorum 75g, Licorice 25g.
[0029] Preparation method: For the above 11 flavors of herbal medicines, Jingjiang, Fangfeng, Qianghuo, Angelica dahur, Qianhuo, Szechuanxiong, and Citrus oleracea are used to extract volatile oils, and Szechuanxiong and Citrus oleracea are used to extract aqueous solutions by distillation separately. The residues of Szechuanxiong and Citrus oleracea after aqueous solution extraction and Poria cocos are filtered to make a 25% ethanol solution with the above aqueous solution to obtain an extract. The residues of Jingjiang, Fangfeng, Qianghuo, Angelica oleracea, and Qianhu after aqueous solution extraction are combined with three herbal medicines such as Bupleurum Root, Platycodon grandiflorum, and Licorice Root, and are extracted by boiling in water twice for 1.5 hours each time. The two boiling decoctions obtained are combined, filtered, and concentrated to obtain a paste. The extract and paste are mixed, left to stand, filtered, and the filtrate is concentrated into a paste with a density of 1.30 (80-85℃). Add 6 parts of sucrose to a paste with a mass ratio of 1, mix evenly, dry, add to the volatile oil such as scutellaria obtained above, mix evenly and prepare.
[0030] Example 2 Granule Formulation Formulation: Jinghu 50g Windproof 50g Qianghu 50g Dokatsu 50g Saihu 50g Qianhu 50g Kawa▲Kyu▼ 50g, Kikko 50g, Poria cocos 50g, Platycodon grandiflorum 50g, Licorice 5g.
[0031] Preparation method: same as in Example 1.
[0032] Example 3 Granule Formulation Formulation: Jinghu 100g Windproof 100g Qianghu 100g Dokatsu 100g Chaihu 100g Qianhu 100g Kawa▲Kyu▼ 100g, Kikko 100g, Poria cocos 100g, Platycodon grandiflorum 100g, Licorice 50g.
[0033] Preparation method: same as in Example 1.
[0034] Example 4 Preparation of a combination drug (commercially available powdered combination of schizophrenia and rotting toxins) Formulation: Jinghu 97g Windproof 97g Qianghu 97g Dokatsu 97g Saihu 97g Qianhu 97g Kawa▲Kyu▼ 97g, Kikko Root 97g, Poria Cocos Root 97g, Platycodon Root 97g, Licorice Root 32.4g.
[0035] Preparation method: Volatile oils are extracted from each of Jingjiang, Fangfeng, Qiang Huo, Angelica Root, Citrus Szechuan, and Qianhu by distillation, and the aqueous solution after distillation is stored separately. The residue after aqueous solution extraction of Citrus Szechuan, Citrus Root, and Poria Cocos are filtered to make a 25% ethanol solution with the above aqueous solution, and the extract is obtained by filtration, and the ethanol is removed by vacuum method. The residue after aqueous solution extraction of the remaining five-flavor herbs is combined with Bupleurum Root, Platycodon Root, and Licorice Root, and boiled three times with water, filtered, and the filtrate is combined and concentrated to 1300ml. The concentrated solution is combined with the above solution from which the ethanol has been removed, left to stand, filtered, and concentrated to 1000ml. Finally, 3g of sodium benzoate and the above volatile oil are added, stirred, and water is added to prepare 1000ml.
[0036] Control Example 1: Decoction (liquid) Saiku 30g Yellow▲Gon▼ 17g Jinghu 14g Windproof 15g Shirofuji 15g Tenma 15g Whole scorpion 15g, licorice 10g, open bone grass 15g, Qianghu 20g, earth dragon 20g Preparation method: Make 500ml of decoction using standard decoction methods.
[0037] Control Example 2: Decoction (liquid) Jingkuta 10g Windproof 10g Saiku 12g Yellow▲Gon▼ 10g Chikatsu 10g Dokatsu 10g Kawa▲Kyu▼ 12g 10g mint, 10g gold and silver flower, 10g forsythia, 10g white ▲shi▼, 20g kudzu root, 15g white snake tongue grass 10g red peony, 10g burdock root, 9g licorice Preparation method: Make 500ml of decoction using standard decoction method.
[0038] Control Example 3: Decoction (liquid) 10g of sclerotium, 10g of wind-resistant sclerotium, 12g of bupleurum, 10g of shang ▲ gong ▼, 10g of qiang ▲ kyu ▼, 12g of angelica 10g 10g of thin cargo, 10g of gold and silver flowers, 10g of lentils, 20g of arrowroot, 15g of white flowers, 6g of cicadas 10g of red peony, 10g of burdock, 9g of licorice, 10g of shoma g stone 10g iris Preparation method: Make 500ml of decoction using standard decoction method.
[0039] Pharmacodynamic experiments The present inventor conducts relevant pharmacodynamic experimental research to prove the effectiveness of Jingfang Baidu Powder preparation in the treatment of facial nerve disorders in the present invention. Note that the following experimental research is carried out based on acute toxicity test and long-term toxicity test to prove the safety of the drug, and the drug dosage in the experimental research is within the range of safe dosage. The drug selected for the following pharmacodynamic test is the representative preparation of the present invention, and the present inventor also conducts pharmacodynamic experiment for other preparations of the present invention, and the results have the same or similar effect, but due to space limitations, they are not described here.
[0040] In addition, the following pharmacodynamic experiments merely use some animal models as examples to verify the effectiveness of the present invention, and this instruction manual only presents the results of the pharmacodynamic experiments of the herbal medicine composition of the present invention on facial nerve disorders. For other types of neuropathy mentioned in the present invention and neuropathy caused by other causes, the inventor has also conducted relevant pharmacodynamic experiments, and the results show that they have the same or similar effects, and the results of the pharmacodynamic experiments will not be listed here.
[0041] 1. Material 1.1 Experimental Drugs and Reagents 1.1.1 Drugs The granules obtained in Examples 1, 2 and 3 of the present invention, Example 4 Combination drug, Control decoctions obtained in Examples 1-3.
[0042] 1.1.2 Dosage Example 1 Granules: 2.02 g / kg (small amount), 4.05 g / kg (medium amount), 8.10 g / kg (large amount), Example 2 Granules: 4.05 g / kg, Example 3 Granules: 4.05 g / kg, Example 4 combination: 4.05 ml / kg, Control Example 1 Decoction: 18ml / kg, Control Example 2 Decoction: 18ml / kg, Control Example 3 Decoction: 18ml / kg, 1.2 Experimental animals SPF SD rats, weighing 180-220g, experimental animal permit number: SYXK(Lu) 20180008, provided by Lunan Pharmaceutical Group Co., Ltd., were given a preliminary breeding period of one week for acclimatization.
[0043] 2. Experimental Method 2.1 Model creation procedures and grouping Several rats, both male and female, were prepared, and an appropriate amount of ether was poured into a small pecan, the cotton was completely soaked, and the ether container was closed. The pecan filled with ether was placed in the rat anesthesia box, and the rat was quickly transferred to the box and the anesthesia box was tightly closed. After observing that the rat had collapsed and its breathing had slowed, it was removed from the anesthesia box and its corneal reflex and pain reflex were examined. The tip of the hemostat was gently touched to the rat's cornea, and if the rat did not close its eyes or make any avoidance movements, this indicated that the corneal reflex had disappeared. Next, the rat's toes were pinched with moderate force by the hemostat, and if the rat did not struggle or make any avoidance movements, this indicated that the pain reflex had disappeared, and this meant that general anesthesia had been achieved. After that, the right side of the rat's face was turned up and fixed to the operating table. Since the right side of the face was the surgical site, it was disinfected with 1% iodine. A skin incision of about 1 cm was made from the center of the line connecting the center of the right auricle to the pupil of the right eye of the rat, and the incision was made perpendicular to the line, and the subcutaneous dissection of the incision was performed to reach the muscle layer. The dissected rat facial nerve was dissected along the buccal branches toward the right auricle of the rat until the right facial nerve trunk was exposed. The facial nerve trunk was dissected and the facial nerve was clamped with the tip of a needle holder for 90 s. After completing the injury with the clamp, the wound was closed with 3-0 nylon and erythromycin ointment was applied to prevent infection. Rats that had been successfully modeled were prepared and divided into a model group, three groups of Example 1 (high dose group, medium dose group, low dose group), Example 2-4 groups, and control Example 1-3 groups, with 10 rats (5 males and 5 females) and half male and half female. The control group consisted of 10 rats (5 males and 5 females), and the surgical procedures were almost the same as those described above, except that the right facial nerve trunk was only avulsed and not damaged.
[0044] 2.2 Administration The rats in each group were orally administered the above-specified drugs, and the control group and the model group were given the same amount of saline once a day for 14 days.
[0045] 3.Statistical analysis Statistical analysis was performed using the statistical software SPSS 22.0. The results are displayed in file TIFF0007588759000001.tif5170. One-way analysis of variance was used for comparisons across all groups. Independent sample t-tests were used for comparisons between each pair of groups. P < 0.05 was used as the statistical significance level.
[0046] 4. Study index and experimental results 4.1 Rat ethological scores 4.1.1 Evaluation Criteria TIFF0007588759000002.tif66170TIFF0007588759000003.tif571704.1.2 Statistical results TIFF0007588759000004.tif125170
[0047] TIFF0007588759000005.tif132170
[0048] The comparison results of the facial nerve disorder behavioral scores of each group of rats showed that at 0 days after administration, the control group and the model group were significantly different from the three groups of Example 1 (high dose group, medium dose group, low dose group), the groups of Examples 2-4, and the groups of Control Examples 1-4 (P<0.01), indicating that the model was successfully created. Also, at 14 days after administration, the control group and the model group were significantly different from the three groups of Example 1 (high dose group, medium dose group, low dose group), the groups of Examples 2-4, and the groups of Control Examples 1-4 (P<0.01).
[0049] 4.2 VEGFb, VEGFR1 and VEGFR2 protein levels in the unilateral facial nerve of rats after surgery 14 days after administration TIFF0007588759000006.tif138170
[0050] TIFF0007588759000007.tif138170
[0051] TIFF0007588759000008.tif138170
[0052] Therefore, the results of the above pharmacodynamic experiments show that the herbal medicine composition of the present invention can significantly alleviate facial paralysis and other symptoms associated with facial nerve disorders in rats, significantly enhance the detection of VEGFb, VEGFR1 and VEGFR2 proteins in the unilateral facial nerve of rats after surgery, and promote the recovery and regeneration of damaged axons, indicating that the herbal medicine composition of the present invention is effective in the treatment of facial nerve disorders.
[0053] 4.3 Facial nerve conduction velocity on one side of the rat after surgery 14 days after administration After 14 days of administration, the rats were anesthetized intraperitoneally by injection, and the facial nerve was dissected. Stimulating and recording electrodes were set on the dissected facial nerve from the proximal end to the distal end. Nerve conduction velocity CV (ms -1 ) = distance between stimulating and recording electrodes / transmission time, 10 measurements were taken and the average value was calculated.
[0054] As shown in Figure 1, after 14 days of administration, each group of rats underwent nerve conduction velocity tests, and the model group and the control group showed significant differences compared with the three groups in Example 1 (high dose group, medium dose group, low dose group) and the groups in Examples 2-4 (P<0.01).
[0055] Figure 2 shows a comparison of the facial nerve conduction velocity of rats in the model group, control group and Examples 1-3 groups. The data shows that the herbal medicine composition provided in the examples of the present invention can stimulate the facial nerve of rats and is effective in treating facial nerve disorders.
[0056] 4.4 The amount of Beclin 1 protein and p62 protein found in rat facial nerve tissue After 14 days of treatment, the amount of Beclin 1 protein detected in the facial nerve tissue of rats was measured by immunohistochemical staining, and the amount of P62 protein detected in the facial nerve tissue was measured by RT-PCR.
[0057] Figure 3-6 shows the comparison of Beclin1 protein and P62 protein in facial nerve tissue after 14 days of administration to rats. The results show that the herbal composition of the present invention suppresses the amount of Beclin1 protein in rat facial nerve tissue, increases the amount of P62 protein, and promotes the functional recovery of the facial nerve. The model group and the control group were significantly different from the three groups in Example 1 (high dose group, medium dose group, low dose group) and the groups in Examples 2-4 (P<0.01).
[0058] As shown by the rat behavior scores, the herbal medicine composition of the present invention can significantly alleviate facial paralysis, motor disorder and other symptoms associated with facial nerve disorders in rats. It can significantly increase the expression levels of VEGFb, VEGFR1 and VEGFR2 proteins in the unilateral facial nerve of rats after surgery, and promote the recovery and regeneration of damaged axons. It can also stimulate the rat facial nerve and increase the nerve conduction speed. It can suppress the detection amount of Beclin1 protein and increase the detection amount of P62 protein in the facial nerve tissue, and promote the functional recovery of the facial nerve. Therefore, the herbal medicine composition of the present invention is effective against facial nerve disorders and can alleviate the symptoms associated with facial nerve disorders.
Claims
1. Use of a herbal composition comprising the following herbal ingredients in the manufacture of a medicament for treating facial nerve disorders: 50-100 parts by weight of Qiang Huo, 50-100 parts by weight of Dianthus Root, 50-100 parts by weight of Poria Cocos, 50-100 parts by weight of Bouquet of Flowers, 50-100 parts by weight of Szechuan Qiu, 50-100 parts by weight of Platycodon Root, 50-100 parts by weight of Bupleurum Root, 50-100 parts by weight of Qianhuang Hu, 50-100 parts by weight of Citrus Fruit Root and 5-50 parts by weight of Licorice Root.
2. The use according to claim 1, characterized in that the herbal composition comprises 75 weight parts of Scutellaria Root, 75 weight parts of Fangfeng Root, 75 weight parts of Qiang Huo, 75 weight parts of Eucalyptus Root, 75 weight parts of Bupleurum Root, 75 weight parts of Qiang Huo, 75 weight parts of Szechuan Qiu, 75 weight parts of Citrus Fruit Root, 75 weight parts of Poria Root, 75 weight parts of Platycodon Root, and 25 weight parts of Licorice Root.
3. The use according to claim 1, characterized in that the facial nerve disorder is caused by one or more of the following causes: infection, toxic substances, genetic factors, nutritional disorders, immune diseases, metabolic disorders, endocrine metabolic disorders, congenital malformations, blood circulation disorders, hyperplasia, cold, and injury.
4. The herbal medicine composition can improve the symptoms of facial nerve disorder, The symptoms include irritation and / or elimination symptoms, The use according to claim 1, characterized in that the irritation symptoms are symptoms manifested as pain and numbness, and the loss symptoms are symptoms manifested as sensory dullness / loss and motor paralysis.
5. The herbal medicine composition can improve the symptoms of facial nerve disorder, 2. The use according to claim 1, characterized in that the symptoms include one or more of the following: shallowing of the nasolabial folds, deviation of the corners of the mouth to one side, dripping water from the mouth, inability to control voluntary facial movements, widening of the eyelids, inability to wrinkle, close the eyes, or whistle, and inability to make facial expressions.
6. The herbal composition may be prepared by using pharma- ceutically acceptable additives; The use according to any one of claims 1 to 5, characterized in that the formulation comprises granules, combinations, tablets, capsules, powders, syrups, microcapsules, and ointments.
7. The said herbal medicine composition is a preparation of Jingbo Haidoku Powder; The use according to claim 1, characterized in that the preparation of Jingbo-Haidoku-san is a granule of Jingbo-Haidoku-san or a combination of Jingbo-Haidoku-san.
Citation Information
Patent Citations
Chinese medicine preparation for curing facial paralysis
CN101926903A
Traditional Chinese medicine for treating facial paralysis
CN102793855A
Traditional Chinese medicine for treating peripheral facial paralysis
CN103393863A
Traditional Chinese medicine decoction for treating facial paralysis
CN104383173A
Traditional Chinese medicine composition for treating peripheral facial paralysis
CN105106802A
